Lexeo Therapeutics Stock (NASDAQ: LXEO) stock price, news, charts, stock research, profile.
You can purchase shares of Lexeo Therapeutics (NASDAQ:LXEO) through any online brokerage.
Other companies in Lexeo Therapeutics’s space includes: Macrogenics (NASDAQ:MGNX), Precigen (NASDAQ:PGEN), Zentalis Pharma (NASDAQ:ZNTL), Inozyme Pharma (NASDAQ:INZY) and Fate Therapeutics (NASDAQ:FATE).
Lexeo Therapeutics has a consensus price target of $22.71.
The stock price for Lexeo Therapeutics (NASDAQ: LXEO) is $8.05 last updated November 14, 2024 at 6:09 PM EST.
There are no upcoming dividends for Lexeo Therapeutics.
Lexeo Therapeutics’s Q4 earnings are confirmed for Tuesday, November 26, 2024.
There is no upcoming split for Lexeo Therapeutics.
Lexeo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.